Workflow
Sera Prognostics(SERA)
icon
Search documents
Down -30.54% in 4 Weeks, Here's Why Sera Prognostics (SERA) Looks Ripe for a Turnaround
ZACKS· 2025-05-13 14:35
Sera Prognostics, Inc. (SERA) has been beaten down lately with too much selling pressure. While the stock has lost 30.5% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.Guide to Identifying Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscil ...
SERA PROGNOSTICS APPOINTS LEE ANDERSON AS CHIEF COMMERCIAL OFFICER
Prnewswire· 2025-05-08 20:40
"Lee is a highly accomplished leader with commercial expertise in fostering innovation, supporting continuous optimization and driving sales and offers a history of strong performance within the healthcare and diagnostics space," said Zhenya Lindgardt, President and CEO of Sera Prognostics. "With Sera now in the commercial phase following the strong results of our pivotal PRIME study, Lee will play a critical role in expanding adoption and sales of our PreTRM Test and we enthusiastically welcome Lee to our ...
Sera Prognostics, Inc. (SERA) Reports Q1 Loss, Misses Revenue Estimates
ZACKS· 2025-05-07 23:00
This quarterly report represents an earnings surprise of 16.67%. A quarter ago, it was expected that this company would post a loss of $0.23 per share when it actually produced a loss of $0.25, delivering a surprise of -8.70%. Sera Prognostics, Inc. (SERA) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.25 per share a year ago. These figures are adjusted for non-recurring items. There are no easy answers to this key questi ...
Sera Prognostics(SERA) - 2025 Q1 - Earnings Call Transcript
2025-05-07 22:02
Sera Prognostics (SERA) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Company Participants Peter Denardo - PresidentZhenya Lindgardt - President & CEOAustin Aerts - Chief Financial Officer Conference Call Participants None - AnalystDaniel Brennan - Analyst Operator Good afternoon, and welcome to the SeraPrognostics Conference Call to Review First Quarter Fiscal Year twenty twenty five Results. At this time, all participants are in a listen only mode. We will be facilitating a question and answer session to ...
Sera Prognostics(SERA) - 2025 Q1 - Earnings Call Transcript
2025-05-07 22:00
Sera Prognostics (SERA) Q1 2025 Earnings Call May 07, 2025 05:00 PM ET Speaker0 Good afternoon, and welcome to the SeraPrognostics Conference Call to Review First Quarter Fiscal Year twenty twenty five Results. At this time, all participants are in a listen only mode. We will be facilitating a question and answer session toward the end of today's call. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Peter DeNardo of Capcom Partners for a few introduc ...
Sera Prognostics(SERA) - 2025 Q1 - Quarterly Report
2025-05-07 20:12
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-40606 SERA PROGNOSTICS, INC. (Exact Name of Registrant as Specified in its Charter) | Delaware | 26-1911522 | | --- | --- | | (State or other jur ...
Sera Prognostics(SERA) - 2025 Q1 - Quarterly Results
2025-05-07 20:09
Exhibit 99.1 "Following the results of our full PRIME pivotal study being publicized we are leveraging them by engaging with key plan providers in focused geographic regions hard hit by premature birth," said Zhenya Lindgardt, President and CEO of Sera Prognostics. "While it will take some time to evolve, we anticipate that Medicaid providers in those areas will see the positive impact PreTRM can make in healthcare cost savings and patient outcomes, furthering adoption of the test." First Quarter 2025 Finan ...
Sera Prognostics(SERA) - 2024 Q4 - Earnings Call Transcript
2025-03-20 04:49
Sera Prognostics (SERA) Q4 2024 Earnings Call March 20, 2025 12:49 AM ET Company Participants Peter Denardo - PresidentZhenya Lindgardt - President & CEOAustin Aerts - Chief Financial OfficerDaniel Brennan - Managing Director Conference Call Participants Maggie Boeye - Equity Research Analyst Operator Good afternoon and welcome to the Serra Prognostics Conference Call to review Factor Fiscal Year twenty twenty four Results. At this time, all participants are in listen only mode. We will be facilitating a qu ...
Sera Prognostics(SERA) - 2024 Q4 - Earnings Call Transcript
2025-03-19 23:13
Sera Prognostics Inc (NASDAQ:SERA) Q4 2024 Earnings Conference Call March 19, 2025 5:00 PM ET Company Participants Peter DeNardo - IR, CapComm Partners Evguenia Lindgardt - President, CEO & Director Austin Aerts - CFO Conference Call Participants Dan Brennan - TD Cowen Margarate Boeye - William Blair Operator Good afternoon, and welcome to the Sera Prognostics Conference Call to review Fourth Quarter Fiscal Year 2024 Results. At this time, all participants are in listen-only mode. We will be facilitating a ...
Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Misses Revenue Estimates
ZACKS· 2025-03-19 22:20
Sera Prognostics, Inc. (SERA) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -8.70%. A quarter ago, it was expected that this company would post a loss of $0.22 per share when it actually produced a loss of $0.24, delivering a surprise of -9.09%.Over the last four quarters, the company has n ...